TY - JOUR
T1 - Mechanisms of hepatocyte protection against hypoxic injury by atrial natriuretic peptide
AU - Carini, Rita
AU - De Cesaris, Maria Grazia
AU - Splendore, Roberta
AU - Domenicotti, Cinzia
AU - Nitti, Maria Paola
AU - Pronzato, Maria Adelaide
AU - Albano, Emanuele
N1 - Funding Information:
Supported by grants from the University “Amedeo Avogadro” of East Piedmont and the Italian Ministry for Instruction, University and Scientific Research (Research Program: Molecular Mechanisms of Protection of Steatotic Liver Against Ischemia Reperfusion).
PY - 2003/2/1
Y1 - 2003/2/1
N2 - Atrial natriuretic peptide (ANP) reduces ischemia and/or reperfusion damage in several organs, but the mechanisms involved are largely unknown. We used freshly isolated rat hepatocytes to investigate the mechanisms by which ANP enhances hepatocyte resistance to hypoxia. The addition of ANP (1 μmol/L) reduced the killing of hypoxic hepatocytes by interfering with intracellular Na+ accumulation without ameliorating adenosine triphosphate (ATP) depletion and pH decrease caused by hypoxia. The effects of ANP were mimicked by 8-bromo-guanosine 3′, 5′-cyclic monophosphate (cGMP) and were associated with the activation of cGMP-dependent kinase (cGK), suggesting the involvement of guanylate cyclase-coupled natriuretic peptide receptor (NPR)-A/B ANP receptors. However, stimulating NPR-C receptor with des-(Gln18, Ser19,Gly20,Leu21,Gly22)-ANP fragment 4-23 amide (C-ANP) also increased hepatocyte tolerance to hypoxia. C-ANP protection did not involve cGK activation but was instead linked to the stimulation of protein kinase C (PKC)-δ through Gi protein- and phospholipase C-mediated signals. PKC-δ activation was also observed in hepatocytes receiving ANP. The inhibition of phospholipase C or PKC by U73122 and chelerythrine, respectively, significantly reduced ANP cytoprotection, indicating that ANP interaction with NPR-C receptors also contributed to cytoprotection. In ANP-treated hepatocytes, the stimulation of both cGK and PKC-δ was coupled with dual phosphorylation of p38 mitogen-activated protein kinase (MAPK). The p38 MAPK inhibitor SB203580 abolished ANP protection by reverting p38 MAPK-mediated regulation of Na+ influx by the Na+/H+ exchanger. In conclusion, ANP recruits 2 independent signal pathways, one mediated by cGMP and cGK and the other associated with Gi proteins, phospholipase C, and PKC-δ. Both cGK and PKC-δ further transduce ANP signals to p38 MAPK that, by maintaining Na+ homeostasis, are responsible for ANP protection against hypoxic injury.
AB - Atrial natriuretic peptide (ANP) reduces ischemia and/or reperfusion damage in several organs, but the mechanisms involved are largely unknown. We used freshly isolated rat hepatocytes to investigate the mechanisms by which ANP enhances hepatocyte resistance to hypoxia. The addition of ANP (1 μmol/L) reduced the killing of hypoxic hepatocytes by interfering with intracellular Na+ accumulation without ameliorating adenosine triphosphate (ATP) depletion and pH decrease caused by hypoxia. The effects of ANP were mimicked by 8-bromo-guanosine 3′, 5′-cyclic monophosphate (cGMP) and were associated with the activation of cGMP-dependent kinase (cGK), suggesting the involvement of guanylate cyclase-coupled natriuretic peptide receptor (NPR)-A/B ANP receptors. However, stimulating NPR-C receptor with des-(Gln18, Ser19,Gly20,Leu21,Gly22)-ANP fragment 4-23 amide (C-ANP) also increased hepatocyte tolerance to hypoxia. C-ANP protection did not involve cGK activation but was instead linked to the stimulation of protein kinase C (PKC)-δ through Gi protein- and phospholipase C-mediated signals. PKC-δ activation was also observed in hepatocytes receiving ANP. The inhibition of phospholipase C or PKC by U73122 and chelerythrine, respectively, significantly reduced ANP cytoprotection, indicating that ANP interaction with NPR-C receptors also contributed to cytoprotection. In ANP-treated hepatocytes, the stimulation of both cGK and PKC-δ was coupled with dual phosphorylation of p38 mitogen-activated protein kinase (MAPK). The p38 MAPK inhibitor SB203580 abolished ANP protection by reverting p38 MAPK-mediated regulation of Na+ influx by the Na+/H+ exchanger. In conclusion, ANP recruits 2 independent signal pathways, one mediated by cGMP and cGK and the other associated with Gi proteins, phospholipase C, and PKC-δ. Both cGK and PKC-δ further transduce ANP signals to p38 MAPK that, by maintaining Na+ homeostasis, are responsible for ANP protection against hypoxic injury.
UR - http://www.scopus.com/inward/record.url?scp=0037309587&partnerID=8YFLogxK
U2 - 10.1053/jhep.2003.50033
DO - 10.1053/jhep.2003.50033
M3 - Article
SN - 0270-9139
VL - 37
SP - 277
EP - 285
JO - Hepatology
JF - Hepatology
IS - 2
ER -